Caliway Biopharmaceuticals Co., Ltd. (TPE:6919)
Taiwan
· Delayed Price · Currency is TWD 111.00
+10.00 (9.90%)
Apr 29, 2026, 1:30 PM CST
TPE:6919 Market Cap
TPE:6919 has a market cap or net worth of 157.19 billion as of April 28, 2026. Its market cap has increased by 13.54% in one year.
Market Cap
157.19B
Enterprise Value
152.30B
Revenue
38.04M
Ranking
n/a
PE Ratio
n/a
Stock Price
111.00
Market Cap Chart
Since December 26, 2022, TPE:6919's market cap has increased from 7.96B to 157.19B, an increase of 1,875.18%. That is a compound annual growth rate of 144.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 157.19B | -34.57% |
| Dec 31, 2025 | 240.25B | 154.60% |
| Dec 31, 2024 | 94.36B | 300.87% |
| Dec 29, 2023 | 23.54B | 212.69% |
| Dec 30, 2022 | 7.53B | -5.41% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pell Bio-Med Technology | 48.93B |
| Lin BioScience | 34.74B |
| Oneness Biotech | 25.16B |
| Sunmax Biotechnology | 21.21B |
| Lumosa Therapeutics | 20.94B |
| AP Biosciences | 16.30B |
| Medigen Vaccine Biologics | 15.78B |
| Polaris Group | 15.01B |